NeuroVive Pharmaceutical AB organizacji FCF yield
Jaka jest wartość FCF yield organizacji NeuroVive Pharmaceutical AB?
Wartość FCF yield organizacji NeuroVive Pharmaceutical AB to -456.11%
Jaka jest definicja FCF yield?
Free cash flow yield (FCF yield) is a financial ratio that compares the free cash flow per share to the market value per share. The ratio is calculated by dividing free cash flow per share by the current share price.
ttm (trailing twelve months)
Free cash flow yield is a good measure of the company’s cash flow in respect to the company’s size. Larger companies tend to have a higher cash flow yield, but it’s not always the case. The higher the free cash flow yield, the more cash the company is generating that can be quickly accessed to satisfy its obligations. The lower the free cash flow yield, the more money investors are putting into the company with little result. The higher the ratio, the more attractive the investment is as it suggests that investors are paying less for each unit of free cash flow.
Free cash flow acts as an indicator of how capable a company is of repaying all of its obligations. It is a solid indicator of how financially stable a company is. It is calculated as:
Free cash flow yield = Free cash flow per share / market price per share
FCF yield firm w Health Care sektor na OTC w porównaniu do NeuroVive Pharmaceutical AB
Czym się zajmuję organizacja NeuroVive Pharmaceutical AB?
Abliva AB (publ), a pharmaceutical company, engages in the research and development of mitochondrial medicine. The company is developing KL1333 that is in Phase I clinical trials for the chronic treatment of primary mitochondrial diseases; NV354, which is in the preparation for clinical trials for the treatment of primary mitochondrial diseases with Complex I deficiency; and NeuroSTAT for traumatic brain injury. It has collaboration agreements with Isomerase, Yungjin Pharm, University of Pennsylvania, Children's Hospital of Philadelphia, Patheon, and Oroboros Instruments. The company was formerly known as NeuroVive Pharmaceutical AB (publ) and changed its name to Abliva AB (publ) in May 2020. Abliva AB (publ) was incorporated in 2000 and is headquartered in Lund, Sweden.
Firmy z fcf yield podobne do NeuroVive Pharmaceutical AB
- Wartość FCF yield organizacji EVIO to -476.77%
- Wartość FCF yield organizacji Shift Technologies to -471.17%
- Wartość FCF yield organizacji Redhill Biopharma to -469.50%
- Wartość FCF yield organizacji Spring Bank Pharmaceuticals to -466.79%
- Wartość FCF yield organizacji Jinshang Bank Co to -456.80%
- Wartość FCF yield organizacji Metro Bank Plc to -456.35%
- Wartość FCF yield organizacji NeuroVive Pharmaceutical AB to -456.11%
- Wartość FCF yield organizacji Aeglea BioTherapeutics Inc to -455.63%
- Wartość FCF yield organizacji Evofem Biosciences Inc to -451.94%
- Wartość FCF yield organizacji Nabriva Therapeutics Plc to -450.47%
- Wartość FCF yield organizacji China XD Plastics Co Ltd to -450.12%
- Wartość FCF yield organizacji Amicus Therapeutics to -441.27%
- Wartość FCF yield organizacji Clearford Water Systems to -440.49%